Position in AKBA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$50,027
-$5,953 QoQ
Shares Held
43,884
+9.0% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 170 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PRUDENTIAL FINANCIAL INC holds $156,689,854 across 37 Drug Manufacturers - Specialty & Generic names. AKBA ranks #34 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
178,605 | $30,102,086 | |
| 2 | ZTS |
Zoetis Inc.
|
200,280 | $14,392,120 | |
| 3 | VTRS |
Viatris Inc
|
849,694 | $13,493,139 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
262,336 | $10,763,646 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
424,167 | $10,438,749 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
216,865 | $10,251,208 | |
| 7 | LQDA |
Liquidia Corp
|
122,836 | $9,793,714 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
16,798 | $9,101,659 |
All Filings in AKBA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,027 | 43,884 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $55,980 | 40,274 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $82,953 | 51,524 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $765,923 | 280,558 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,511,120 | 415,143 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $124,106 | 64,639 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $122,491 | 64,469 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $85,099 | 64,469 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $14,554 | 14,269 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $69,739 | 38,109 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $27,415 | 22,109 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $54,160 | 47,509 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $43,470 | 47,509 | Shares | Defined | 2023-08-11 | |
| 2022-03-31 | $179,436 | 249,912 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,425,861 | 630,912 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,121,646 | 1,083,905 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $79,745 | 21,041 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $62,236 | 18,386 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $51,312 | 18,326 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $45,998 | 18,326 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $158,437 | 11,667 | Shares | Defined | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||